Your browser doesn't support javascript.
loading
COVID-19 vaccine safety inquiries to the centers for disease control and prevention immunization safety office.
Miller, Elaine R; Moro, Pedro L; Shimabukuro, Tom T; Carlock, Grace; Davis, Shaeyla N; Freeborn, Emma M; Roberts, Amy L; Gee, Julianne; Taylor, Allan W; Gallego, Ruth; Suragh, Tiffany; Su, John R.
Affiliation
  • Miller ER; Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: erm4@cdc.gov.
  • Moro PL; Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Shimabukuro TT; Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Carlock G; Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Davis SN; Deputy Director for Infectious Disease, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Freeborn EM; Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Roberts AL; Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Gee J; Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Taylor AW; Global Health Center, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Gallego R; Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Suragh T; Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Su JR; Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Vaccine ; 41(27): 3960-3963, 2023 06 19.
Article in En | MEDLINE | ID: mdl-37248099
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Vaccines / COVID-19 Limits: Female / Humans / Pregnancy Country/Region as subject: America do norte Language: En Journal: Vaccine Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Vaccines / COVID-19 Limits: Female / Humans / Pregnancy Country/Region as subject: America do norte Language: En Journal: Vaccine Year: 2023 Document type: Article